Stock-Based Compensation and Shareholders' Equity

6 Months Ended

May 04, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation and Shareholders' Equity

A summary of the Company’s stock option activity as of May 4, 2019 and changes during the three- and six-month periods then ended is presented below:



Activity during the Three Months Ended May 4, 2019	Options Outstanding (in thousands)		Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Term in Years	Aggregate Intrinsic Value
Options outstanding at February 2, 2019	6,741			$60.03
Options granted	413			$108.08
Options exercised	(1,294	)		$52.60
Options forfeited	(38	)		$75.43
Options outstanding at May 4, 2019	5,822			$64.99	6.3		$302,503
Options exercisable at May 4, 2019	3,443			$54.70	5.2		$214,319
Options vested or expected to vest at May 4, 2019 (1)	5,626			$64.30	6.2		$296,225


(1)	In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.



Activity during the Six Months Ended May 4, 2019	Options Outstanding (in thousands)		Weighted- Average Exercise Price Per Share
Options outstanding at November 3, 2018	7,297			$58.42
Options granted	439			$107.08
Options exercised	(1,806	)		$48.44
Options forfeited	(103	)		$72.06
Options expired	(5	)		$21.97
Options outstanding at May 4, 2019	5,822			$64.99

During the three- and six-month periods ended May 4, 2019, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $72.6 million and $99.7 million, respectively, and the total amount of proceeds received by the Company from the exercise of these options was $67.7 million and $86.9 million, respectively.

During the three- and six-month periods ended May 5, 2018, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $28.7 million and $82.5 million, respectively, and the total amount of proceeds received by the Company from the exercise of these options was $27.7 million and $65.6 million, respectively.

A summary of the Company’s restricted stock unit/award activity as of May 4, 2019 and changes during the three- and six-month periods then ended is presented below:



Activity during the Three Months Ended May 4, 2019	Restricted Stock Units/Awards Outstanding (in thousands)		Weighted- Average Grant- Date Fair Value Per Share
Restricted stock units/awards outstanding at February 2, 2019	4,985			$77.76
Units/Awards granted	1,144			$98.90
Restrictions lapsed	(1,074	)		$64.18
Forfeited	(77	)		$78.81
Restricted stock units/awards outstanding at May 4, 2019	4,978			$85.49

Activity during the Six Months Ended May 4, 2019	Restricted Stock Units/Awards Outstanding (in thousands)		Weighted- Average Grant- Date Fair Value Per Share
Restricted stock units/awards outstanding at November 3, 2018	5,289			$77.54
Units/Awards granted	1,200			$98.06
Restrictions lapsed	(1,331	)		$66.00
Forfeited	(180	)		$78.58
Restricted stock units/awards outstanding at May 4, 2019	4,978			$85.49

As of May 4, 2019, there was $395.6 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options and restricted stock units/awards. That cost is expected to be recognized over a weighted-average period of 1.6 years. The total grant-date fair value of shares that vested during the three- and six-month periods ended May 4, 2019 was approximately $87.1 million and $106.4 million, respectively. The total grant-date fair value of shares that vested during the three- and six-month periods ended May 5, 2018 was approximately $64.1 million and $84.5 million, respectively.

Common Stock Repurchases

As of May 4, 2019, the Company had repurchased a total of approximately 152.0 million shares of its common stock for approximately $5.8 billion under the Company's share repurchase program. As of May 4, 2019, an additional $2.3 billion remains available for repurchase of shares under the current authorized program.